Why the study?
Does the reperfusion strategy (Primary PCI, Pharmacoinvasive PCI, or Delayed PCI) improve left ventricular ejection fraction and reduce mortality in patients with STEMI and acute total occlusion?
Cohort (n=94)
No
Does the reperfusion strategy (Primary PCI, Pharmacoinvasive PCI, or Delayed PCI) improve left ventricular ejection fraction and reduce mortality in patients with STEMI and acute total occlusion?
Primary PCI provides immediate LVEF improvement before discharge, while pharmacoinvasive and delayed PCI strategies also yield significant LVEF recovery at 1 and 6 months in STEMI patients.
Answers are grounded in this paper and cite their sources.
Primary PCI may support early LVEF gains in STEMI; leaves open long-term equivalence to pharmacoinvasive strategy in observational data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sudeb Mukherjee (2018) conducted a cohort in ST-Segment Elevation Myocardial Infarction (STEMI) with acute total occlusion of coronary artery (n=94). Primary PCI vs. Pharmacoinvasive PCI and Delayed PCI was evaluated on Left ventricular ejection fraction at 6 months (Primary PCI vs Pharmacoinvasive PCI) (p=0.74).
Synapse has enriched 10 related papers. Consider them for comparative context: